Laura Phyllis Perry, MD | |
10330 Se 32nd Ave Ste 205, Milwaukie, OR 97222-6594 | |
(503) 513-8950 | |
Not Available |
Full Name | Laura Phyllis Perry |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Location | 10330 Se 32nd Ave Ste 205, Milwaukie, Oregon |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912296799 | NPI | - | NPPES |
Entity Name | Regents Of The University Of California |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881763597 PECOS PAC ID: 4284547274 Enrollment ID: O20031106000389 |
News Archive
Scientists in France have designed a new system for molecular blood group typing that offers blood banks the possibility of extensive screening of blood donors at a relatively low cost. Their approach is described in the current issue of The Journal of Molecular Diagnostics.
With a 2019 Australian study finding that only just over half (54%) of children treated in general practice were managed following Australian and international pediatric asthma clinical practice guidelines, the latest educational program from NPS MedicineWise launching today will provide an opportunity for health professionals to refresh their knowledge about basic principles in diagnosing and managing asthma for children of different ages.
ANI Pharmaceuticals, Inc., an emerging generic pharmaceutical company, today announced that it has acquired 31 previously marketed generic drug products from Teva Pharmaceuticals for $12.5 million in cash and a percentage of future gross profits from product sales.
Tibion, a leading provider of bionic devices for rehabilitation and mobility, announced today it has received TÜV certification for its PK100 Bionic Leg Orthosis. The Tibion PK100 product has been tested and evaluated for compliance with internationally recognized standards for the safety of medical products.
› Verified 7 days ago
Entity Name | University Of California San Francisco |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861578973 PECOS PAC ID: 4486567229 Enrollment ID: O20031212000897 |
News Archive
Scientists in France have designed a new system for molecular blood group typing that offers blood banks the possibility of extensive screening of blood donors at a relatively low cost. Their approach is described in the current issue of The Journal of Molecular Diagnostics.
With a 2019 Australian study finding that only just over half (54%) of children treated in general practice were managed following Australian and international pediatric asthma clinical practice guidelines, the latest educational program from NPS MedicineWise launching today will provide an opportunity for health professionals to refresh their knowledge about basic principles in diagnosing and managing asthma for children of different ages.
ANI Pharmaceuticals, Inc., an emerging generic pharmaceutical company, today announced that it has acquired 31 previously marketed generic drug products from Teva Pharmaceuticals for $12.5 million in cash and a percentage of future gross profits from product sales.
Tibion, a leading provider of bionic devices for rehabilitation and mobility, announced today it has received TÜV certification for its PK100 Bionic Leg Orthosis. The Tibion PK100 product has been tested and evaluated for compliance with internationally recognized standards for the safety of medical products.
› Verified 7 days ago
Entity Name | Ucsf Medical Group Business Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477624104 PECOS PAC ID: 3779497870 Enrollment ID: O20040622001513 |
News Archive
Scientists in France have designed a new system for molecular blood group typing that offers blood banks the possibility of extensive screening of blood donors at a relatively low cost. Their approach is described in the current issue of The Journal of Molecular Diagnostics.
With a 2019 Australian study finding that only just over half (54%) of children treated in general practice were managed following Australian and international pediatric asthma clinical practice guidelines, the latest educational program from NPS MedicineWise launching today will provide an opportunity for health professionals to refresh their knowledge about basic principles in diagnosing and managing asthma for children of different ages.
ANI Pharmaceuticals, Inc., an emerging generic pharmaceutical company, today announced that it has acquired 31 previously marketed generic drug products from Teva Pharmaceuticals for $12.5 million in cash and a percentage of future gross profits from product sales.
Tibion, a leading provider of bionic devices for rehabilitation and mobility, announced today it has received TÜV certification for its PK100 Bionic Leg Orthosis. The Tibion PK100 product has been tested and evaluated for compliance with internationally recognized standards for the safety of medical products.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Laura Phyllis Perry, MD Po Box 3158, Portland, OR 97208-3158 Ph: (503) 215-6494 | Laura Phyllis Perry, MD 10330 Se 32nd Ave Ste 205, Milwaukie, OR 97222-6594 Ph: (503) 513-8950 |
News Archive
Scientists in France have designed a new system for molecular blood group typing that offers blood banks the possibility of extensive screening of blood donors at a relatively low cost. Their approach is described in the current issue of The Journal of Molecular Diagnostics.
With a 2019 Australian study finding that only just over half (54%) of children treated in general practice were managed following Australian and international pediatric asthma clinical practice guidelines, the latest educational program from NPS MedicineWise launching today will provide an opportunity for health professionals to refresh their knowledge about basic principles in diagnosing and managing asthma for children of different ages.
ANI Pharmaceuticals, Inc., an emerging generic pharmaceutical company, today announced that it has acquired 31 previously marketed generic drug products from Teva Pharmaceuticals for $12.5 million in cash and a percentage of future gross profits from product sales.
Tibion, a leading provider of bionic devices for rehabilitation and mobility, announced today it has received TÜV certification for its PK100 Bionic Leg Orthosis. The Tibion PK100 product has been tested and evaluated for compliance with internationally recognized standards for the safety of medical products.
› Verified 7 days ago
Dr. Scott Keola Miyake, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6902 Se Lake Rd, Ste 100, Milwaukie, OR 97267 Phone: 503-786-1167 Fax: 503-786-1153 | |
Ms. Yufei Zhang, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10024 Se 32nd Ave, Milwaukie, OR 97222 Phone: 503-659-4988 Fax: 503-654-5666 | |
Mr. David R. Maslen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10024 Se 32nd Ave, Milwaukie, OR 97222 Phone: 503-659-4988 Fax: 503-654-5666 | |
Leah A Swetnam, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6902 Se Lake Rd, Milwaukie, OR 97267 Phone: 503-786-1150 | |
Steven J Redmond, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10150 Se 32nd Ave, Milwaukie, OR 97222 Phone: 503-513-8695 | |
Dr. Stacie Lorraine Carney, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 10330 Se 32nd Ave Ste 325, Milwaukie, OR 97222 Phone: 503-416-1960 Fax: 503-416-1959 | |
Mr. Dennis O. Mayer, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 10024 Se 32nd Ave, Milwaukie, OR 97222 Phone: 503-659-4988 Fax: 503-654-5666 |